Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 12
Submit an article Journal homepage
3,063
Views
13
CrossRef citations to date
0
Altmetric
Reviews

Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines

Qian-qian DuKey Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics, Laboratory of Microbiology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, ChinaView further author information
,
Wei ShiKey Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics, Laboratory of Microbiology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, ChinaView further author information
,
Dan YuKey Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics, Laboratory of Microbiology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, ChinaView further author information
&
Kai-hu YaoKey Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics, Laboratory of Microbiology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1548-8670View further author information
ORCID Icon
Pages 5628-5637 | Received 14 Jun 2021, Accepted 20 Sep 2021, Published online: 02 Nov 2021

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Miwa Haranaka, Makoto Yono, Hiroyuki Kishino, Rie Igarashi, Nobuyuki Oshima, Miyuki Sawata & Heather Loryn Platt. (2023) Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in Japanese healthy adults: A Phase I study. Human Vaccines & Immunotherapeutics 19:2.
Read now

Articles from other publishers (12)

Kate Summer, Lei Liu, Qi Guo, Bronwyn Barkla & Kirsten Benkendorff. (2024) Semi-purified Antimicrobial Proteins from Oyster Hemolymph Inhibit Pneumococcal Infection. Marine Biotechnology.
Crossref
Dorota Borys, Richard Rupp, Ronald Smulders, Gurunadh R. Chichili, Laura L. Kovanda, Vicki Santos, Frank Malinoski, George Siber, Richard Malley & Shite Sebastian. (2024) Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial. Vaccine.
Crossref
Suwon Lim, Dongwook Lee, Sungho Jeong, Jeong Woo Park, Jintaek Im, Bokeum Choi, Donghyun Gwak, Cheol-Heui Yun, Ho Seong Seo & Seung Hyun Han. (2023) Serotype-Dependent Inhibition of Streptococcus pneumoniae Growth by Short-Chain Fatty Acids . Journal of Microbiology and Biotechnology 34:1, pages 47-55.
Crossref
N. N. Kostyukova & V. A. Bekhalo. (2023) Pneumococcal Polysaccharide Conjugated Vaccines and the Problem of Changing Circulating Serotypes of Pneumococcus. Epidemiology and Vaccinal Prevention 22:5, pages 110-120.
Crossref
Mustapha Dibbasey, Mamudou Dahaba, Francess Sarfo, Ida Jallow-Manneh, Buntung Ceesay, Solomon Umukoro, Mouhamadou Fadel Diop & Alfred Amambua-Ngwa. (2023) Laboratory indices of hospitalized sickle cell disease patients, prevalence and antimicrobial susceptibility of pathogenic bacterial isolates at MRCG ward in the Gambia. BMC Infectious Diseases 23:1.
Crossref
Peris Wambugu, Mohammad-Monir Shah, Hien-Anh Nguyen, Kim-Anh Le, Huy-Hoang Le, Hien-Minh Vo, Michiko Toizumi, Minh-Xuan Bui, Duc-Anh Dang & Lay-Myint Yoshida. (2023) Molecular Epidemiology of Streptococcus pneumoniae Detected in Hospitalized Pediatric Acute Respiratory Infection Cases in Central Vietnam. Pathogens 12:7, pages 943.
Crossref
Hieu Cong Truong, Thanh Van Phan, Hung Thanh Nguyen, Khanh Huu Truong, Viet Chau Do, Nguyet Nguyen My Pham, Thang Vinh Ho, Tram Thi Quynh Phan, Thang Anh Hoang, Antoine Soetewey, Thuy Nguyen Loc Ho, Quang Duy Pham, Quang Chan Luong, Dai Thi Trang Vo, Thuong Vu Nguyen & Niko Speybroeck. (2023) Childhood Bacterial Meningitis Surveillance in Southern Vietnam: Trends and Vaccination Implications From 2012 to 2021. Open Forum Infectious Diseases 10:7.
Crossref
Yong Li, Ying Yang, Dafan Chen, Yan Wang, Xinyun Zhang, Wenchao Li, Shengsen Chen, Sandy M. Wong, Mengwen Shen, Brian J. Akerley & Hao Shen. (2023) Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection. mBio.
Crossref
Salini Mohanty, Bélène Podmore, Ana Cuñado Moral, Ian Matthews, Eric Sarpong, Agueda Azpeitia & Nawab Qizilbash. (2023) Healthcare resource utilisation and cost of pneumococcal disease from 2003 to 2019 in children ≤17 years in England. PLOS ONE 18:4, pages e0283084.
Crossref
Thomas Benfield, Mika Rämet, Piero Valentini, Ilkka Seppä, Ron Dagan, Peter Richmond, Swati Mercer, Clay Churchill, Robert Lupinacci, Richard McFetridge, Jun Park, Frederick Wittke, Natalie Banniettis, Luwy Musey, Kara Bickham & Janusz Kaminski. (2023) Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2). Vaccine 41:15, pages 2456-2465.
Crossref
Kei Nakashima, Kanzo Suzuki, Masahiro Aoshima, Mayumi Murabata, Kyoko Kondo, Satoko Ohfuji, Wakaba Fukushima, Akiko Maeda & Yoshio Hirota. (2022) Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in older individuals after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multicenter hospital-based case-control study in Japan. Vaccine 40:46, pages 6589-6598.
Crossref
Yali Cui, Chenglin Miao, Wen Chen, Wenling Shang, Qianqian Qi, Wei Zhou, Xia Wang, Yingying Li, Ziyi Yan & Yongmei Jiang. (2022) Construction and protective efficacy of a novel Streptococcus pneumoniae fusion protein vaccine NanAT1-TufT1-PlyD4. Frontiers in Immunology 13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.